AzTrials
AzTrials

SleepNCT06787378

The Sweet Dreams Study - Accuracy of Sleep Trackers in Children

An observational study of Sleep, run by Arkansas Children's Hospital Research Institute at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to evaluate the accuracy of sleep trackers in children aged 2 to less than 18 years. Children undergoing polysomnography, the gold standard for assessing sleep quality and duration, at Arkansas Children's Hospital may be eligible to participate. Read more about this study

Who is it for?
Ages 2 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Sleep
How many people
300 participants
Where
2 sitesUnited States
Study dates
1 Mar 2025to 28 Feb 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children ages 2 to < 18years

Who may be able to join

  • Age 2 to <18 years
  • All BMIs
  • Scheduled at PSDC for evaluation of obstructive sleep apnea, snoring, or noisy breathing during sleep.

Who cannot join

  • Known diagnosis of sleep disorder
  • Neurological disorders (e.g., epilepsy, cerebral palsy, etc.)
  • Autism spectrum disorder
  • Attention deficit hyperactivity disorder
  • Oppositional defiant disorder
  • Chronic kidney disease
Show all 15Show fewer
  • Hormonal disease
  • Autoimmune diseases
  • Bleeding disorders
  • Chronic infections (e.g., HIV, hepatitis B)
  • Mental health disorders (e.g., depression, anxiety)
  • Liver disease (e.g. hepatitis)
  • Referral for evaluation of disorders other than obstructive sleep apnea, snoring, or noisy breathing during sleep.
  • Pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest.
  • Refusal to authorize study investigators to access data from the polysomnography test conducted at the Arkansas Children's Hospital PSDC.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites, 2 recruiting
  • Arkansas Children's Hospital

    Little Rock, Arkansas, 72202

    Eva C Diaz, MD, 501-364-3056, ecdiazfuentes@uams.edu

    Eva C Diaz, MD

    Recruiting
  • Arkansas Children's Nutrition Center

    Little Rock, Arkansas, 72211

    EVA DIAZ FUENTES, 832-272-3876, ecdiazfu@gmail.com

    Eva C Diaz, MD, 501-364-3056, ecdiazfuentes@uams.edu

    Recruiting

Other trials in United States

About this study

The study aims to evaluate the accuracy of sleep trackers in children aged 2 to less than 18 years. Children undergoing polysomnography, the gold standard for assessing sleep quality and duration, at Arkansas Children's Hospital may be eligible to participate. Participants will be asked to wear sleep trackers on the day of their sleep test. The data collected from the sleep trackers will be compared with the polysomnography results to determine the devices' accuracy.

Read the detailed description

Participants will meet the research team at Arkansas Children's Hospital (ACH) two to three hours before their scheduled sleep test and are required to bring a stool sample from the child to the visit.

During the visit, the research team will gather information about the child's home environment and medical history, including parent marital status, parental education level, household income, and other factors. Questionnaires will also cover topics such as the child's growth and development, diet, physical activity, use of substances like tobacco and alcohol, and mood. Any questions that cause discomfort may be skipped by the child or their parent.

A brief physical exam will be conducted to measure the child's weight, height, blood pressure, and heart rate. Sleep trackers will then be programmed and placed, with two worn on the wrist and two around the waist. Instructions on how to remove and reattach the trackers will be provided to ensure proper use.

After completing the sleep test at ACH, the sleep trackers must be left in the sleep clinic. All four trackers must be returned, and parents will be asked to report if the trackers were removed at any point during the study.

Conditions
Sleep
Keywords
sleep, accelerometer, polysomnography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06787378
Study groupRoleWhat they receive
ChildrenChildren ages 2 to <18 years of age will be enrolled

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total sleep time

    sleep minutes between lights off and lights on

    Measured: Up to 10 days after consent

  2. Wake after sleep onset

    wake minutes between PSG-scored sleep onset and lights on

    Measured: Up to 10 days after consent

  3. Sleep efficiency

    Total sleep time divided by sleep period or number of total min from lights off to lights on

    Measured: Up to 10 days after consent

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2025
  2. Study start1 Mar 2025
  3. Primary completion28 Feb 2029 (estimated)
  4. Study completion28 Feb 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06787378
Sponsor's protocol ID
275668
Status last verified
Jan 2025
First submitted
10 Jan 2025
Last updated
3 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: study protocol, and consent, analytic code

Publications

  • Lu MJ, Zhong WH, Liu YX, Miao HZ, Li YC, Ji MH. Sample Size for Assessing Agreement between Two Methods of Measurement by Bland-Altman Method. Int J Biostat. 2016 Nov 1;12(2):/j/ijb.2016.12.issue-2/ijb-2015-0039/ijb-2015-0039.xml. doi: 10.1515/ijb-2015-0039.

    PubMed 27838682
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.

    PubMed 2868172
  • Smith C, Galland B, Taylor R, Meredith-Jones K. ActiGraph GT3X+ and Actical Wrist and Hip Worn Accelerometers for Sleep and Wake Indices in Young Children Using an Automated Algorithm: Validation With Polysomnography. Front Psychiatry. 2020 Jan 14;10:958. doi: 10.3389/fpsyt.2019.00958. eCollection 2019.

    PubMed 31992999
  • Quante M, Kaplan ER, Cailler M, Rueschman M, Wang R, Weng J, Taveras EM, Redline S. Actigraphy-based sleep estimation in adolescents and adults: a comparison with polysomnography using two scoring algorithms. Nat Sci Sleep. 2018 Jan 18;10:13-20. doi: 10.2147/NSS.S151085. eCollection 2018.

    PubMed 29403321

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep, run by Arkansas Children's Hospital Research Institute at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eva C Diaz, MD (5013646056, ecdiazfuentes@uams.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total sleep time (time frame: Up to 10 days after consent). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06787378, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in